JetBlue Airways Corporation (NASDAQ:JBLU) will begin twice-daily nonstop service from BWI Thurgood Marshall Airport to Fort Lauderdale-Hollywood International Airport in November, the airline said Thursday. The new service between BWI and Fort Lauderdale will “give Maryland and Washington area residents a convenient option to get away and enjoy many of South Florida’s premier leisure destinations, as well as the ability to connect on to JetBlue’s diverse network throughout the Caribbean, Central and South America,” the company said in a release. On Thursday shares of JetBlue Airways Corporation (NASDAQ:JBLU) closed at $17.35. Company’s sales growth for last 5 years was 12.10% and EPS growth for next 5 years is recorded as 43.30%.
Cytori Therapeutics, Inc. (Nasdaq:CYTX) announced that it received approval from FDA to expand the number of Scleroderma clinical trial sites from 12 to 20 centers in the United States. The STAR study is an 80 patient pivotal clinical trial approved by FDA in January 2015 to study the effects of Cytori’s lead drug ECCS-50 for treatment of patients with hand manifestations of Scleroderma. Cytori Therapeutics, Inc. (NASDAQ:CYTX) in last trading activity moved up 56.94% to close at $1.13. Company weekly performance is 105.45% while its quarterly performance stands at 156.82%. Cytori Therapeutics, Inc. (NASDAQ:CYTX) is -66.07% away from its 52 week high.
On February 23, ONEOK Inc. (NYSE:OKE) reported fourth-quarter 2014 adjusted earnings of 45 cents per share, surpassing the Zacks Consensus Estimate of 37 cents by 21.6%.On a GAAP basis, the company reported earnings of $1.49 per share in 2014 versus $1.27 per share a year ago. On last trading day ONEOK Inc. (NYSE:OKE) fell -3.13% to close at $43.97. Its volatility for the week is 2.93% while volatility for the month is 3.28%. OKE’s sales growth for past 5 years was -2.00% and its EPS growth for past 5 years was -2.90%. ONEOK Inc. (NYSE:OKE) monthly performance is -0.25%.
Haemonetics Corporation (NYSE:HAE) announced that Brian Concannon, President & CEO, will present at the Raymond James 36th Annual Institutional Investors Conference in Orlando, FL on Tuesday, March 3, 2015 at 2:50 pm Eastern time. Haemonetics Corporation (NYSE:HAE) has 0.60% insider ownership. In last trading activity company’s stock closed at $45.25.
Stifel Nicolaus cut shares of Marvell Technology Group (NASDAQ:MRVL) from a buy rating to a hold rating in a research report sent to investors on Wednesday morning,TheFlyOnTheWall.com reports. Marvell Technology Group Ltd. (NASDAQ:MRVL) in last trading activity moved down -1.47% to close at $16.10. Company weekly performance is -1.83% while its quarterly performance stands at 16.25%. Marvell Technology Group Ltd. (NASDAQ:MRVL) is -4.05% away from its 52 week high.